2.31 (-%)
As of Dec 12, 2024
Source:
Inflarx N.V. is a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system. We do this by applying our proprietary technologies to discover, develop and commercialize first-in-class, highly potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR.
Country | Germany |
Headquarters | jena, germany |
Phone Number | 49 (3641) 508 180 |
Industry | manufacturing |
CEO | Niels Riedemann |
Website | www.inflarx.com |